Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
An 82% reduction in liver fat with retatrutide could potentially address the disease at an earlier, more reversible stage
En casos extremos, se produce insuficiencia renal, que puede ser mortal
Important safety note: Because retatrutide is unlicensed in the UK, there is no MHRA-approved Summary of Product Characteristics or monitoring recommendations for routine clinical use, and there is no regulated supply chain
Age range The safety and efficacy of Ozempic have not been established in pediatric patients younger than 18 years of age
US$ 29.73
US$ 22.68
US$ 24.94
US$ 25.96
US$ 22.33
US$ 23.82
US$ 23.32
US$ 21.94
